File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Adiponectin: mechanisms and new therapeutic approaches for restoring diabetic heart sensitivity to ischemic post-conditioning

TitleAdiponectin: mechanisms and new therapeutic approaches for restoring diabetic heart sensitivity to ischemic post-conditioning
Authors
KeywordsAdiponectin
Ischemic post-conditioning
Ischemia reperfusion injury
Diabetes
Issue Date2013
PublisherHigher Education Press & Springer -Verlag GmbH. The Journal's web site is located at http://www.springer.com/medicine/journal/11684
Citation
Frontiers of Medicine, 2013, v. 7 n. 3, p. 301-305 How to Cite?
AbstractSystemic inflammatory response following myocardial ischemia-reperfusion injury (IRI) to a specific organ may cause injuries. Ischemic post-conditioning (IPostC) has emerged as a promising method for myocardial protection against IRI both in experimental and in clinical settings. Enhancement of endogenous nitric oxide (NO) is one of the major mechanisms by which IPostC confers cardioprotection. However, the sensitivity of the diabetic heart to IPostC is impaired and the underlying mechanism is unknown. Adiponectin (APN) is an adipocytederived plasma protein with anti-diabetic and anti-inflammatory properties. Plasma levels of APN are decreased in obese subjects and in patients with type 2 diabetes. APN supplementation has been shown to increase NO production and attenuate myocardial IRI in normal (non-diabetic) animals. However, the effect of APN on myocardial injury in diabetic subjects, especially its potential in restoring the sensitivity of the diabetic heart to IPostC has not been investigated. In the current paper, we discussed the possible reasons why the myocardium of diabetic subjects loses sensitivity to IPostC and also highlighted the potential effectiveness and mechanism of APN in restoring IPostC cardioprotection in diabetes. This review proposes to conduct studies that may facilitate the development of novel and optimal therapies to enhance cardioprotection in patients with severe diseases such as diabetes.
Persistent Identifierhttp://hdl.handle.net/10722/188833
ISSN
2019 Impact Factor: 3.421
2015 SCImago Journal Rankings: 0.995
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorWang, T-
dc.contributor.authorYao, S-
dc.contributor.authorXia, Z-
dc.contributor.authorIrwin, MG-
dc.date.accessioned2013-09-17T14:16:49Z-
dc.date.available2013-09-17T14:16:49Z-
dc.date.issued2013-
dc.identifier.citationFrontiers of Medicine, 2013, v. 7 n. 3, p. 301-305-
dc.identifier.issn2095-0217-
dc.identifier.urihttp://hdl.handle.net/10722/188833-
dc.description.abstractSystemic inflammatory response following myocardial ischemia-reperfusion injury (IRI) to a specific organ may cause injuries. Ischemic post-conditioning (IPostC) has emerged as a promising method for myocardial protection against IRI both in experimental and in clinical settings. Enhancement of endogenous nitric oxide (NO) is one of the major mechanisms by which IPostC confers cardioprotection. However, the sensitivity of the diabetic heart to IPostC is impaired and the underlying mechanism is unknown. Adiponectin (APN) is an adipocytederived plasma protein with anti-diabetic and anti-inflammatory properties. Plasma levels of APN are decreased in obese subjects and in patients with type 2 diabetes. APN supplementation has been shown to increase NO production and attenuate myocardial IRI in normal (non-diabetic) animals. However, the effect of APN on myocardial injury in diabetic subjects, especially its potential in restoring the sensitivity of the diabetic heart to IPostC has not been investigated. In the current paper, we discussed the possible reasons why the myocardium of diabetic subjects loses sensitivity to IPostC and also highlighted the potential effectiveness and mechanism of APN in restoring IPostC cardioprotection in diabetes. This review proposes to conduct studies that may facilitate the development of novel and optimal therapies to enhance cardioprotection in patients with severe diseases such as diabetes.-
dc.languageeng-
dc.publisherHigher Education Press & Springer -Verlag GmbH. The Journal's web site is located at http://www.springer.com/medicine/journal/11684-
dc.relation.ispartofFrontiers of Medicine-
dc.rightsThe final publication is available at Springer via http://dx.doi.org/10.1007/s11684-013-0283-1-
dc.subjectAdiponectin-
dc.subjectIschemic post-conditioning-
dc.subjectIschemia reperfusion injury-
dc.subjectDiabetes-
dc.titleAdiponectin: mechanisms and new therapeutic approaches for restoring diabetic heart sensitivity to ischemic post-conditioning-
dc.typeArticle-
dc.identifier.emailWang, T: wangtt6@hku.hk-
dc.identifier.emailXia, Z: zyxia@hkucc.hku.hk-
dc.identifier.emailIrwin, MG: mgirwin@hku.hk-
dc.identifier.authorityXia, Z=rp00532-
dc.identifier.authorityIrwin, MG=rp00390-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1007/s11684-013-0283-1-
dc.identifier.pmid23904036-
dc.identifier.scopuseid_2-s2.0-84883459752-
dc.identifier.hkuros221849-
dc.identifier.volume7-
dc.identifier.issue3-
dc.identifier.spage301-
dc.identifier.epage305-
dc.identifier.isiWOS:000209571300005-
dc.publisher.placeBerlin-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats